-
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
CRI Scientist Receives Russian Federation National Award
Sergei Nedospasov, PhD, D.Sc., was honored for his contributions to the molecular mediators of immunity, including work…
-
Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy
A retrospective study finds that immunotherapies are safe and work in many patients with preexisting autoimmune diseases.
-
Rational Combinations 360° Conference Will Feature Two of CRI’s Leading Scientists
The inaugural Rational Combinations 360° is a novel two-day forum on June 23-24, 2016, that will provide…
-
Oncogene Initiates Cancer Development through Immune Checkpoints
CLIP investigator Dean W. Felsher, MD, PhD, published his findings in the journal Science.
-
Laurie H. Glimcher, MD, to Head Dana-Farber Cancer Institute
CRI Scientific Advisory Council member Laurie H. Glimcher, MD, will become the next president and CEO of…
-
FDA Regulatory Definitions
You heard that a drug in clinical trials was Fast Tracked. Or you heard that a treatment…
-
ASCO Names Cancer Immunotherapy “Advance of the Year”
ASCO President: “No recent cancer advance has been more transformative than immunotherapy.”
-
#WeCanICan: The Cure is International
World Cancer Day is both a celebration of the progress we’ve made so far, and a call…
